The utility of multiplex NAT in blood screening

Developments in Biologicals

Volumn 127, Issue , 2007, Pages 71-86

  Candotti, D ^a   Allain, J P ^b,c  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c Cambridge Blood Centre   (United Kingdom)

Author keywords

Blood safety; Bloodborne viruses; Multiplex; NAT

Indexed keywords

BLOOD BANK; BLOOD DONOR; CONFERENCE PAPER; GENETICS; HUMAN; MASS SCREENING; METHODOLOGY; NUCLEIC ACID AMPLIFICATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIREMIA; VIRUS;

BLOOD BANKS; BLOOD DONORS; HUMANS; MASS SCREENING; NUCLEIC ACID AMPLIFICATION TECHNIQUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VIREMIA; VIRUSES;

EID: 34247115493     PISSN: 14246074     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (54)

1. Caudai C, Padula MG, Bettini V, Valensin PE: Detection of HCV and GBV-C/HGV infection by multiplex PCR in plasma samples of transfused subjects. J Virol Methods 1998; 70: 79-83.
2. Defoort J-P, Martin M, Casano B, Prato S, Camilla C, Fert V: Simultaneous detection of multiplex-amplified human immunodeficiency virus type 1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA using a flow cytometer microsphere-based hybridization assay. J Clin Microbiol 2000; 38: 1066-1071.
3. Cleland A, Davis C, Adams N, Lycett C, Jarvis LM, Holmes H, Simmonds P: Development of multiplexed nucleic acid testing for human immunodeficiency virus type 1 and hepatitis C virus. Vox Sang 2001; 81: 93-101.
4. Adami V, Falasca E, Dorotea L, Malangone W, Astori G, Marini L, Biffoni F, Rinaldi C, Degrassi A, Pipan C: Qualitative multiplex RT-PCR for simultaneous detection of hepatitis C virus and human immunodeficiency virus in plasma samples. Clin Microbiol Infect 2004; 10: 1075-1080.
5. Mercier B, Burlot L, Ferec C: Simultaneous screening for HBV DNA and HCV RNA genomes in blood donations using a novel TaqMan PCR assay. J Virol Methods 1999; 77: 1-9.
6. Vet JAM, Majithia AR, Marras SAE, Tyagi S, Dube S, Poiesz BJ, Kramer FR: Multiplex detection of four pathogenic retroviruses using molecular beacons. Proc Natl Acad Sci USA 1999; 96: 6394-6399.
7. Abravaya K, Esping C, Hoenle R, Gorzowski J, Perry R, Kroeger P, Robinson J, Flanders R: Performance of a multiplex qualitative PCR LCx assay for detection of human immunodeficiency virus type 1 (HIV-1) group M subtypes, group O, and HIV-2. J Clin Microbiol 2000; 38: 716-723.
8. Meng Q, Wong C, Rangachari A, Tamatsukuri S, Sasaki M, Fiss E, Cheng L, Ramankutty T, Clarke D, Yawata H, Sakakura Y, Hirose T, Impraim C: Automated multiplex assay system for simultaneous detection of hepatitis B virus DNA, hepatitis C virus RNA, and human immunodeficiency virus type 1 RNA. J Clin Mcrobiol 2001; 39: 2937-2947.
9. Candotti D, Temple J, Owusu-Ofori S, Allain J-P: Multiplex real-time quantitative RT-PCR assay for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus type 1. J Virol Methods 2004; 118: 39-47.
10. Dineva MA, Candotti D, Fletcher-Brown F, Allain J-P, Lee H : Simultaneous visual detection of multiple viral amplicons by dipstick assay. J Clin Microbiol 2005; 43: 4015-4021.
11. de Baar MP, van Dooren MW, de Rooij E, Bakker M, van Gemen B, Goudsmit J, de Ronde A: Single rapid real-time monitored isothermal RNA amplification assay for quantification of human immunodeficiency virus type 1 isolates from groups M, N, and O. J Clin Microbiol 2001; 39: 1378-1384.
12. Candotti D, Richetin A, Cant B, Temple J, Sims C, Reeves I, Barbara JAJ, Allain J-P: Evaluation of a transcription-mediated amplification-based HCV and HIV-1 RNA duplex assay for screening individual blood donations : a comparison with a minipool testing system. Transfusion 2003; 43: 215-225.
13. Koppelman HGM, Assal A, Chudy M, Torres P, Garcia de Villaescusa R, Reesink HW, Lelie PN, Cuypers HTM: Multicenter performance evaluation of a transcription-mediated amplification assay for screening of human immunodeficiency virus-1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA in blood donations. Transfusion 2005; 45: 1258-1266.
14. Cleland A, Nettleton P, Jarvis LM, Simmonds P: Use of bovine viral diarrhoea virus as an internal control for amplification of hepatitis C virus. Vox Sang 1999; 76: 170-174.
15. Tucker RA, Unger ER, Holloway BP, Swan DC: Real-time PCR-based fluorescent assay for quantitation of human papillomavirus types 6, 11, 16, and 18. Molecular Diagnosis 2001; 6: 39-47.
16. Bustin SA: Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems. J Mol Endocrin 2002; 29: 23-39.
17. Wittwer CT, Herrmann MG, Gundry CN, Elenitoba-Johnson KSJ: Real-time multiplex PCR assays. Methods 2001; 25: 430-442.
18. Mackay IM, Arden KE, Nitsche A: Real-time PCR in virology. Nucl Acids Res 2002; 30: 1292-1305.
19. Holland PM, Abramson RD, Watson R, Gelfand DH: Detection of specific polymerase chain reaction product by utilizing the 5' → 3' exonuclease activity of Thermus aquaticus DNA polymerase. Proc Natl Acad Sci USA 1991; 88: 7276-7280.
20. Exner MM, Lewinski MA: Sensitivity of multiplex real-time PCR reactions, using the LighyCycler and the ABI PRISM 7700 Sequence Detection System, is dependent on the concentration of the DNA polymerase. Molecular & Cellular Probes 2002; 16: 351-357.
21. Persson K, Hamby K, Ugozzoli LA: Four-color multiplex reverse transcription polymerase chain reaction - overcoming its limitations. Anal Biochem 2005; 344: 33-42.
22. Henegariu O, Heerema NA, Dlouhy SR, Vance GH, Vogt PH : Multiplex PCR : critical parameters and step-by-step protocol. BioTechniques 1997; 23: 504-511.
23. Elnifro EM, Ashshi A, Cooper RJ, Klapper PE: Multiplex PCR: optimization and application in diagnostic virology. Clin Microbiol Rev 2000; 13: 559-570.
24. Schutten M, van den Hoogen B, van der Ende ME, Gruters RA, Osterhaus ADME, Niesters HGM: Development of a real-time quantitative RT-PCR for the detection of HTV-2 RNA in plasma. J Virol Methods 2000; 88: 81-87.
25. Lanciotti RS, Kerst AJ: Nucleic acid sequence-based amplification assays for rapid detection of West Nile and St. Louis Encephalitis viruses. J Clin Microbiol 2001; 39: 4506-4513.
26. Vogelstein B, Gillespie D: Preparative and analytical purification of DNA from agarose. Proc Natl Acad Sci USA 1979; 76: 615-619.
27. Giachetti C, Linnen JM, Kolk DP, Dockter J, Gillotte-Taylor K, Park M, Ho-Sing-Loy M, McCormick MK, Mimms LT, McDonough SH : Highly sensitive multiplex assay for detection of human immunodeficiency virus type 1 and hepatitis C virus RNA. J Clin Microbiol 2002; 40: 2408-2419.
28. Rosenstraus M, Wang Z, Chang S-Y, DeBonville D, Spadoro JP: An internal control for routine diagnostic PCR: design, properties, and effect on clinical performance. J Clin Microbiol 1998; 36: 191-197.
29. Mine H, Emura H, Miyamoto M, Tomono T, Minegishi K, Murokawa H, Yamanaka R, Yoshikawa A, Nishioka K, Japanese Red Cross NAT Research Group : High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus type 1 by nucleic acid amplification testing with specific and sensitive multiplex reagents in Japan. J Virol Methods 2003; 112: 145-151.
30. Pasloske BL, Walkerpeach CR, Obermoeller RD, Winkler M, DuBois DB: Armored RNA technology for production of ribonuclease-resistant viral RNA controls and standards. J Clin Microbiol 1998; 36: 3590-3594.
31. Drosten C, Seifried E, Roth WK: TaqMan 5'-nuclease human immunodeficiency virus type 1 PCR assay with phage-packaged competitive internal control for high-throughput blood donor screening. J Clin Microbiol 2001; 39: 4302-4308.
32. Eisler DL, McNabb A, Jorgensen DR, Isaac-Renton JL: Use of an internal positive control in a multiplex reverse transcription-PCR to detect West Nile virus RNA in mosquito pools. J Clin Microbiol 2004; 42: 841-843.
33. Aubin J-T, Defer C, Vidaud M, Maniez Montreuil M, Flan B: Large-scale screening for human parvovirus B19 DNA by PCR: application to the quality control of plasma for fractionation. Vox Sang 2000; 78: 7-12.
34. Hofmann MA: Construction of an infectious chimeric classical swine fever virus containing the 5'UTR of bovine viral diarrhea virus, and its application as a universal internal positive control in real-time RT-PCR. J Virol Methods 2003; 114: 77-90.
35. Loussert-Ajaka I, Ly TD, Chaix ML, Ingrand D, Saragosti S, Courouce AM, Brun-Vezinet F, Simon F: HIV-1/HIV-2 seronegativity in HIV-1 subtype O infected patients. Lancet 1994; 343: 1393-1394.
36. Widell A, Elmud H, Persson MH, Jonsson M: Transmission of hepatitis C via both erythrocyte and platelet transfusions from a single donor in serological window-phase of hepatitis C. Vox sang 1996; 71: 55-57.
37. Allain J-P, Hewitt PE, Tedder RS, Williamson LM : Evidence that anti-HBc but not HBV DNA testing may prevent some HBV transmission by transfusion. Br J Haematol 1999; 107: 186-195.
38. Candotti D, Adu-Sarkodie Y, Davies F, Baldrich-Rubio E, Stirrups K, Lee H, Allain J-P: AIDS in an HIV-seronegative Ghanaian woman with intersubtype A/G recombinant HIV-1 infection. J Med Virol 2000; 62: 1-8.
39. Soldan K, Barbara JA, Ramsay ME, Hall AJ: Estimation of the risk of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infectious donations entering the blood supply in England. Vox sang 2003; 84: 274-286.
40. Jackson BR, Busch MP, Stramer SL, AuBuchon JP: The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations. Transfusion 2003; 43: 721-729.
41. Coste J, Reesink HW, Laperche S: International Forum. Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology : update to 2003. Vox Sang 2005; 88: 289-303.
42. Ren F, Wang J, Lu S, Yao F, Zhao H, Zhu F, Bai X, Zheng Y, Gong X, Liu C, Yu L, Shan H: Nucleic amplification testing (NAT) for HIV and HCV among Chinese blood donors. Transfusion 2005; 45 Supp: 91A.
43. Vargo J, Smith K, Knott C, Wang S, Fang C, McDonough S, Giachetti C, Caglioti S, Gammon R, Gilbert D, Jackson JB, Richards W, Stramer S, Mimms L: Clinical specificity and sensitivity of blood screening assay for detection of HIV-1 and HCV RNA. Transfusion 2002; 42: 876-885.
44. Fang CT, Field SP, Busch MP, du P Heyns A: Human immunodeficiency virus-1 and hepatitis C virus RNA among South African blood donors: estimation of residual transfusion risk and yield of nucleic acid testing. Vox Sang 2003; 85: 9-19.
45. Mison L, Seed CR, Margaritis AR, Hyland C, the ARCBS NAT Study Group : Nucleic acid technology screening of Australian blood donors for hepatitis C and human immunodeficiency virus-1 RNA : comparison of two high-throughput testing strategies. Vox Sang 2003; 84: 11-19.
46. Busch MP, Stramer SL, Strong DM, Hewlett IK, Epstein JS: International forum letter. Vox sang 2005; 88: 298-301.
47. Busch MP: Closing the windows on viral transmission by blood transfusion. In: Stramer SL, editor. Blood safety in the new millennium. AABB 2000 Emily Cooley Seminar Book. Bethesda: American Association of Blood Banks 2001:33-54.
48. Stramer SL, Glynn SA. Kleinman SH, Strong DM, Caglioti S, Wright DJ, Dodd RY, Busch MP for the National Heart, Lung, and Blood Institute Nucleic Acid Test Study Group : Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid amplification testing. N Engl J Med 2004; 351: 760-768.
49. Candotti D, Sarkodie F, Allain J-P: Residual risk of transfusion in Ghana. Brit J Haematol 2001; 113: 37-39.
50. Weusten JJ, van Drimmelen HA, Lelie PN: Mathematic modeling of the risk of HBV, HCV, and HIV transmission by window-phase donations not detected by NAT. Transfusion 2002 ; 42: 537-548.
51. Biswas R, Tabor E, Hsia CC, Wright DJ, Laycock ME, Fiebig EW, Peddada L, Smith R, Schreiber GB, Epstein JS, Nemo GJ, Busch MP : Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection. Transfusion 2003; 43: 788-798.
52. Allain J-P: Occult hepatitis B virus infection: implications in transfusion. Vox sang 2004; 86: 83-91.
53. Owusu-Ofori S, Temple J, Sarkodie F, Anokwa M, Candotti D, Allain J-P: predonation screening of blood donors with rapid tests : implementation and efficacy of a novel approach to blood safety in resource-poor settings. Transfusion 2005; 45: 133-140.
54. Li C, Collini P, Danso K, Owusu-Ofori S, Dompreh A, Candotti D, Opare-Sem O, Allain JP: GB virus C and HIV-1 RNA load in single virus and co-infected West African individuals. AIDS 2006; 20: 379-386.